Workflow
券商中国
icon
Search documents
蚂蚁集团,声明!
券商中国· 2025-08-11 07:29
Group 1 - Ant Group has issued a statement denying any plans to collaborate with the People's Bank of China and China Rare Earth Group to create a stablecoin, urging the public to be cautious of misleading information [1] - JD.com has also released a statement refuting false claims regarding its stablecoin products and partnerships, warning users to be vigilant against investment scams [3] - JD.com highlighted its advantages in cross-border payments, including faster transaction speeds, lower costs, and uninterrupted service, while reiterating that its stablecoin has not been officially launched and any related information is fraudulent [5]
沸腾!暴涨近170%!中国,创造历史!
券商中国· 2025-08-11 07:29
Core Viewpoint - The article highlights the significant rise of Chinese innovative drugs in the market, exemplified by the explosive debut of Zhonghui Biopharma-B, which saw a surge of nearly 160% on its first trading day, reflecting a broader trend of growth in the innovative drug sector in China [1][2][6]. Group 1: Zhonghui Biopharma-B Performance - Zhonghui Biopharma-B's stock price increased by 169.7% on its debut, closing with a nearly 160% gain [1][2]. - The company set a lower limit price of HKD 12.9 per share, raising a net amount of HKD 383 million [6]. - The public offering was oversubscribed by 4006.64 times, freezing HKD 210 billion in capital, making it the most oversubscribed biotech stock in Hong Kong this year [6]. Group 2: Growth of Innovative Drugs in China - The share of China's innovative drug BD (business development) transactions in the global market has increased from 10.8% in 2015 to an estimated 52.5% as of August 8, 2023 [9]. - The market size of innovative drugs in China reached CNY 679 billion in 2022, with projections to exceed CNY 1 trillion by 2026 and reach CNY 1.12 trillion by 2027 [9]. - The proportion of innovative drugs in the Chinese pharmaceutical market was 41% in 2022, expected to rise to 50% by 2026 and 51% by 2027 [9]. Group 3: Policy Support for Innovation - The National Healthcare Security Administration (NHSA) has held five meetings focused on supporting innovative drugs and medical devices, emphasizing a complete chain from research and development to payment [10]. - The NHSA's stance is to support genuine innovation while rejecting pseudo-innovation, which is expected to accelerate the global presence of Chinese innovative drugs and benefit patients [10].
胖东来回应“招聘刑释人员”
券商中国· 2025-08-11 04:58
8月10日晚间, 胖东来创始人于东来在社交平台发文,回应" 招聘刑释人员"。说明中称,此次招聘"刑 释人员",是基于人性的善良和美好,希望各个群体的人们都能够得到社会的尊重和关爱。能让每个人有 尊严的生活。 说明称,希望刑释人员群体自身要能够正确阳光乐观地面对,因为已经得到过惩罚,要坚定的放下过往、 总结教训,未来踏踏实实的做好自己。 前述说明倡导社会对刑释人员不歧视、不戴有色眼镜,让他们能够被社会善良宽容的接纳,拥有平等的尊 严、人格和追求生命幸福的机会及权利。 对,因为已经得到过惩罚,要坚定的放下过往、总结教训, 未来踏踏实实的做好自己,把曾经走过的弯路当成生命中的 经历乃至宝贵的教育财富,像一个经历过风雨的传道者一样, 分享给更多的人少走弯路,这也是伟大的价值!同时更应该 能够勇敢坦荡、有尊严的、真诚、善良、健康美好的生活! 通过自身的改变和努力,成为创造和享受美好生活的主人! 坚定向善,坚定理解和包容一切不理解自己的过往的人,毕 竟自己曾经伤害过他人,所以不应因此而痛苦的纠结,影响 自己正常的状态!坚定地学习和拥有专业的创造美好生活的 能力,坚定地按照自己喜欢的健康快乐的生活方式生活!这 是对自己生命 ...
百亿私募格局再生变!量化军团扩容,最新业绩出炉
券商中国· 2025-08-11 04:58
量化与主观百亿私募的"分化"仍在继续。 私募排排网最新数据显示,截至2025年7月底,百亿私募总数维持90家不变。其中,量化机构净增2家至44家, 创历史新高,而主观私募则净减2家至39家。 值得注意的是,随着量化私募的超额业绩持续亮眼,资金正在加速流向量化阵营,百亿私募的版图也在悄然重 塑。 此外,百亿私募也交出了一份亮眼的成绩单。截至2025年7月底,纳入统计的55家百亿私募平均收益达 16.60%,量化私募再度跑赢主观机构,不仅实现"全员盈利",且32家量化私募收益超10%。 百亿量化军团再扩容 百亿私募不仅是规模标杆,更是行业的风向标。 私募排排网数据显示,截至2025年7月底,百亿私募总数为90家,环比持平。但从结构来看,量化与主观策略 呈现明显分化:量化百亿私募增加至44家,占比达49%,净增2家;主观百亿私募降至39家,占比缩至43%, 净减少2家。 具体来看,较6月底,7月有3家私募退出百亿阵营,均为主观私募;3家私募新晋百亿,分别是久期投资、千衍 私募、上海波克私募,除久期投资为主观私募外,其余2家皆为量化私募,核心策略分别为债券策略、股票策 略、多资产策略。 其中,上海波克私募相当"年轻" ...
利好突袭!刚刚,涨停潮!
券商中国· 2025-08-11 04:58
一则停产消息彻底引爆。 8月11日,期货市场开盘,碳酸锂期货所有合约全线涨停。A股、港股锂矿股集体爆发,天齐锂业、江特电机、盛新锂能等多股涨停,赣锋锂业H股一度暴涨超 20%。消息面上,宁德时代8月11日在互动平台表示,公司在宜春项目采矿许可证8月9日到期后已暂停了开采作业。 有分析人士指出,此次停产对碳酸锂的供需平衡利好较大。在三季度碳酸锂供需紧平衡的背景下,此次停产或造成单月数千吨的供应缺口。供给扰动叠加传统补库 季节来临,锂价短期反弹空间较大,碳酸锂涨价有望带动锂电产业链整体价格与盈利的修复。 8月11日,商品期货开盘,碳酸锂期货所有合约全线涨停。其中主力合约开盘直接涨停,涨幅为8%,报81000元/吨。 A股开盘后,锂矿股集体大涨,截至午间收盘,天齐锂业、江特电机、盛新锂能涨停,中矿资源、赣锋锂业、永杉锂业大涨超9%,融捷股份、盐湖股份、雅化集 团、西藏矿业、天华新能等个股跟涨。港股锂业股亦全线大涨,赣锋锂业一度暴涨超20%,天齐锂业一度大涨超18%。 另外,周一早盘澳洲锂矿股也大幅走强,其中Liontown资源有限公司股价一度暴涨超22%,Pilbara矿业有限公司大涨超17%,Mineral资源有 ...
刚刚,直线拉升!美国,重大宣布!
券商中国· 2025-08-11 02:16
美国大动作 美东时间8月10日,据美国国防部官网,美国国防部战略资本办公室宣布发放首笔直接贷款,用于加强美国工业基础并保护关键矿产供应链。作为国防部与 美国稀土矿所有者和运营商MP Materials于2025年7月达成的更广泛协议的一部分,美国国防部战略资本办公室提供了1.5亿美元(约合人民币11亿元)贷 款。 | | | 事关稀土,美国紧急出手。 美东时间8月10日,美国国防部宣布,向稀土矿所有人MP Materials提供1.5亿美元贷款,用于为MP Materials 位于加州芒廷帕斯的现有加工厂提升重稀土 分离能力。受此影响,MP Materials股价在夜盘交易中直线拉升,一度涨超3%。 MP Materials拥有美国唯一一座正在运营的稀土矿,据其最新披露的财报,今年第二季度,MP Materials的 镨钕 氧化物产量激增近120%,达到创纪录的 597吨,预计第三季度产量将环比增长10%至20%。在一系列利好政策的刺激下,其股价持续飙涨,年内累计涨幅已超过367%。 国防部负责研究与工程的副部长埃米尔·迈克尔表示:"通过这笔贷款,我们正在采取果断行动,恢复国内关键矿产供应链,重振我们的工业基 ...
港股仓位,成制胜秘诀?新老基金合同影响公募业绩格局
券商中国· 2025-08-11 02:16
Core Viewpoint - The differences in fund contracts between new and old products have led to a significant performance divergence in public funds, particularly influenced by the inclusion of Hong Kong stocks in investment strategies [1][2][4]. Group 1: Performance Impact of Fund Contracts - A-shares funds that have incorporated Hong Kong stock investments into their contracts have significantly outperformed the market, with all top 20 A-share funds achieving over 70% returns year-to-date as of August 10 [3]. - The top-performing funds, established mostly after 2018, allow for up to 50% of their stock positions to be allocated to Hong Kong stocks, which has been a key factor in their success [3]. - Conversely, funds that do not permit Hong Kong stock investments have generally underperformed, with over 90% of the bottom 10 A-share funds lacking such provisions in their contracts [3]. Group 2: Manager Performance and Contract Limitations - Star fund managers have shown a stark performance split between their new and old funds, with new funds performing well while older funds lag behind due to restrictive contracts [5][6]. - Many of these older funds, established between 2004 and 2014, do not include Hong Kong stocks in their investment scope, limiting their ability to adapt to market opportunities [6]. - For instance, fund managers like Wu Yuanyi have seen their newer products, which include Hong Kong stocks, perform significantly better than older products that do not [6]. Group 3: Contract Modification Considerations - Modifying fund contracts to include Hong Kong stocks could address performance disparities, but this approach is contentious and not universally beneficial for all fund managers [7][8]. - Some fund managers express reluctance to modify contracts, citing unfamiliarity with the Hong Kong market and potential risks associated with expanding investment scopes [8]. - The decision to modify contracts often depends on the individual fund manager's expertise and investment strategy, leading some firms to prefer launching new Hong Kong-themed funds instead of altering existing contracts [7][8].
央行,最新公告!
券商中国· 2025-08-11 02:16
Core Viewpoint - The People's Bank of China conducted a 7-day reverse repurchase operation amounting to 112 billion yuan at an interest rate of 1.40%, maintaining the previous rate, while net liquidity was withdrawn by 432.8 billion yuan due to the maturity of 544.8 billion yuan in reverse repos [1][3]. Summary by Relevant Sections - **Operation Details** - The operation involved a total bid amount of 112 billion yuan, with the same amount being awarded [3]. - The interest rate for the 7-day reverse repurchase operation remained unchanged at 1.40% [1][3]. - **Liquidity Impact** - A total of 544.8 billion yuan in 7-day reverse repos matured today, leading to a net withdrawal of 432.8 billion yuan from the market [1].
北京通报:局级11人、处级161人,违反中央八项规定精神
券商中国· 2025-08-11 02:16
日前,北京市纪委监委公布今年1月至7月查处违反中央八项规定精神问题统计指标表。截至7月31日,累计查处违反中央八项规定精神问题715起,批评教育帮助和 处理730人,其中局级11人、处级161人、科级及以下558人。 来源:北京日报 责编:罗晓霞 校对:赵燕 在被批评教育帮助和处理的730人中,给予党纪政务处分的569人,其中局级9人、处级97人、科级及以下463人。查处问题类型包括两大类,即形式主义、官僚主义 问题和享乐主义、奢靡之风问题。 | 问题类型 | 级别 | | | | | | | | | | | | | | | | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 形式主义、官僚主义问题 | 享乐主义、奢靡之风问题 | | | | | | | | | | | | | | | | | | | | ...
金融“活水”如何浇灌科技创新“沃土”?银河证券做科技创新的“耐心资本”
券商中国· 2025-08-11 02:16
编者按: 时代之笔擘画新章,金融活水润泽实体。在金融"五篇大文章"铺就的壮阔画卷中,证券业正以创新之墨 挥毫作答。这是服务国家战略的使命担当,更是深化金融供给侧改革的生动实践。证券业以"国之大 者"为经,以"民之关切"做纬,让金融血脉与实体经济同频共振,奏响中国式现代化的资本强音。证券 时报联合中国证券业协会,推出"做好'五篇大文章' 证券业作答进行时"系列专栏, 本篇为系列报道之 十四,敬请垂注。 金融"活水"如何浇灌科技创新"沃土"?银河证券的实践是不仅要提供资金支持,更要通过"投资+投行"的联动 生态,满足客户日益多元化、个性化、精细化的金融需求。 2024年,致力于为人造设施打造硅光神经感知系统的纤传科技,获得了银河证券直投子公司银河创新资本的领 投。该公司彼时尚处发展早期,但银河证券还是被其技术实力和发展潜力所打动。完成领投后,银河创新资本 还积极对接当地招商部门和银行等金融机构,为纤传科技争取更好的扶持政策和银行授信。 这是银河证券做好"科技金融"的一个缩影,也是长期主义价值观与硬科技创新规律的深度耦合。 聚焦科技创新,大力推进相关股债融资 银河证券近年来紧密围绕科技金融进行战略布局,以资本赋能创 ...